BRIM-DOR

What this record means

The record shows that “BRIM‑DOR” is a live, registered mark owned by HARROW IP, LLC, and it is listed on the Supplemental Register. The mark protects pharmaceutical compositions for ophthalmological use, specifically goods described as “Pharmaceutical compositions for ophthalmological use” in class 005, first used in commerce on February 1, 2017. A similar name used in that exact or closely related category would raise the closest concern. The Supplemental Register status means the mark was initially refused for descriptiveness and later amended to the Supplemental Register, as shown by the prosecution history that includes a refusal and subsequent registration on May 7, 2019. The most recent status event is the acceptance of a Section 8 declaration on August 12, 2025, which keeps the mark active for another six years. No enforcement actions, oppositions, or cancellations appear in the supplied history. For someone considering a similar name, the record suggests a meaningful risk if the name is used for ophthalmic pharmaceutical products, but it does not imply control over unrelated uses.